TIMM23 and ovarian cancer: Undoubtedly, the relevance of mitochondrial content for therapy response is evidenced by RNA expression analyses available in TCGA-OV data that show superior overall survival of ovarian cancer patients with high expression of the mitochondrial proteins TFAM and TIMM23.